EUVIMEDEUVIMED entdecken
Systematische ÜbersichtMetaanalyseOpen Access · CC BY 4.0

Prevalence of Pathogenic Variants and Variants of Uncertain Significance in Patients With Epithelial Ovarian Cancer: A Systematic Review and Meta‐Analysis

Wenhao Zhang iD, Daijuan Chen iD, Jing Zeng iD, Rutie Yin iD, Xiang-Yu Meng iD, Qingli Li iD

Human Mutation · 2026-01 · 2026 (1)

DOI: 10.1155/humu/3005037 ↗

Kurz gefasst

Systematische Übersicht in der Zeitschrift Human Mutation, online erschienen am 16.11.2026. Verfasst von Wenhao Zhang und 5 weiteren Autor:innen. Beteiligte Einrichtung: Cancer Center West China Second University Hospital Sichuan University Chengdu China scu.edu.cn. Hauptthemen laut MEDLINE: Carcinoma, Ovarian Epithelial, Ovarian Neoplasms. Die Arbeit nennt 51 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0). Gefördert von: Natural Science Foundation of Hubei Province, National Natural Science Foundation of China, Department of Science and Technology of Sichuan Province.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Variants of uncertain significance (VUS) are increasingly identified when using multigene panel next‐generation sequencing (NGS) for epithelial ovarian cancer (EOC) patients. This meta‐analysis is aimed at estimating the prevalence of pathogenic variants (PV) and VUS in EOC patients receiving multigene panel testing. We retrieved pertinent literature from PubMed, EMBASE, and the Cochrane Library, following the PRISMA 2020. Our analysis included 19 studies involving 3323 patients. Meta‐analysis of proportions via logit transformation was performed. At the gene level, the pooled proportion of tested genes in which at least one PV was detected was 82%, and the corresponding proportion for VUS was 87%. At the patient level, 24% of patients carried at least one PV, and 11% carried at least one VUS. BRCA1/2 mutations accounted for the majority (22%) of PV within the homologous recombination repair (HRR) pathway, whereas expanding testing to additional HRR panels tripled the VUS rate (from 5% to 14%). The difference between PV prevalence and VUS prevalence was significantly greater for classic DNA damage repair (DDR) genes than for other panel genes. BRCA1 , BRCA2 , RAD51D , and RAD51C exhibited the greatest disparities in the proportions of PV and VUS, indicating a positive risk–benefit balance regarding clinical decision‐making. Our findings suggest that the probability of detecting a VUS in other panel genes is significantly higher than in classic DDR genes, highlighting the underreporting of VUS in clinical studies. Routine clinical reporting may prioritize well‐established EOC‐risk genes, with multigene panel testing reserved for selected subgroups. Improving the reporting and classification of VUS is essential, and future studies should prioritize gene‐specific VUS evaluation.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

Carcinoma, Ovarian EpithelialOvarian NeoplasmsFemaleHumansBRCA1 ProteinBRCA2 ProteinGenetic Predisposition to DiseaseGenetic VariationHigh-Throughput Nucleotide SequencingMutationPrevalence

Stichwörter der Autor:innen

epithelial ovarian cancermeta-analysisnext-generation sequencingpathogenic variantsvariants of uncertain significance

Substanzen

BRCA1 ProteinBRCA2 Protein

Autor:innen und Institutionen

  • Cancer Center West China Second University Hospital Sichuan University Chengdu China scu.edu.cn.
  • Key Laboratory of Birth Defects and Related Diseases of Women and Children (Sichuan University) Ministry of Education Chengdu China moe.gov.sa.
  • Department of Obstetrics and Gynecology West China Second University Hospital Sichuan University Chengdu China scu.edu.cn.
  • Health Science Center Hubei Minzu University Enshi China hbmy.edu.cn.

ORCID-Profile: Wenhao Zhang, Daijuan Chen, Jing Zeng, Rutie Yin, Xiang-Yu Meng, Qingli Li

Förderung

  • Natural Science Foundation of Hubei Province
  • National Natural Science Foundation of China
  • Department of Science and Technology of Sichuan Province

Zitieren

APA

Zhang, W., Chen, D., Zeng, J., Yin, R., Meng, X. Y., & Li, Q. (2026). Prevalence of Pathogenic Variants and Variants of Uncertain Significance in Patients With Epithelial Ovarian Cancer: A Systematic Review and Meta‐Analysis. Human Mutation, 2026(1). https://doi.org/10.1155/humu/3005037

Vancouver

Zhang W, Chen D, Zeng J, Yin R, Meng XY, Li Q. Prevalence of Pathogenic Variants and Variants of Uncertain Significance in Patients With Epithelial Ovarian Cancer: A Systematic Review and Meta‐Analysis. Human Mutation. 2026;2026(1). doi:10.1155/humu/3005037

BibTeX
@article{Zhang2026,
  author = {Zhang, Wenhao and Chen, Daijuan and Zeng, Jing and Yin, Rutie and Meng, Xiang-Yu and Li, Qingli},
  title = {Prevalence of Pathogenic Variants and Variants of Uncertain Significance in Patients With Epithelial Ovarian Cancer: A Systematic Review and Meta‐Analysis},
  journal = {Human Mutation},
  year = {2026},
  volume = {2026},
  number = {1},
  doi = {10.1155/humu/3005037}
}
Kostenlos starten →